Director Mary T. Szela resigns from Coherus BioSciences board, no disagreement

Coherus Oncology, Inc.

Mary T. Szela resigned from Coherus board effective August 5, 2021.
Resignation not due to any disagreement with Company's operations, policies or practices.
No replacement director has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mary T. Szela

Director

CHRS · Coherus Oncology, Inc.

Effective: 2021-08-05
Filed: August 11, 2021, 7:59 PM ET

On August 5, 2021, Mary T. Szela resigned from the Board of Directors (the “Board”) of Coherus BioSciences, Inc. (the “Company”), effective immediately upon notice of her resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary T. Szela resigned as Director at Coherus Oncology, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 5, 2021, Mary T. Szela resigned from the Board of Directors (the “Board”) of Coherus BioSciences, Inc. (the “Company”), effective immediately upon notice of her resignation.

View on SEC.gov

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-243344

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.